Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2025
Total Assets: $13.70B
Liabilities Breakdown FY2025
Total Liabilities: $3.36B
Asset Breakdown
Total Assets: $13.70B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.94B | 21.4% |
| Accounts Receivable | $659.6M | 4.8% |
| Inventory | $1.13B | 8.2% |
| Property, Plant & Equipment | $1.81B | 13.2% |
| Goodwill | $1.77B | 12.9% |
| Intangible Assets | $1.13B | 8.2% |
| Other Assets | $4.26B | 31.1% |
Liabilities Breakdown
Total Liabilities: $3.36B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $227.5M | 6.8% |
| Long-Term Debt | $598.3M | 17.8% |
| Other Liabilities | $2.53B | 75.4% |